risperdal News

J&J Hit with Year’s Largest Jury Award Over Marketing Risperdal Drug to Teens

Johnson & Johnson’s Janssen unit was hit with an $8 billion punitive-damages verdict — the largest jury award in the U.S. this year — over its alleged mishandling of an anti-psychotic drug blamed for causing adolescent boys to grow female-sized …

South Carolina High Court Further Reduces Penalty on Janssen Pharmaceuticals

South Carolina’s highest court further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive marketing of an anti-psychotic drug. The decision was to substitute the same verdict the court reached in February in order to correct a …

South Carolina Court Orders J&J to Pay $136M in Risperdal Case

South Carolina’s Supreme Court ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury’s finding that the drugmaker’s Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks. A trial court had earlier …

$1.2B Judgment Against Drug Maker Voided by Arkansas Supreme Court

The Arkansas Supreme Court overturned a $1.2 billion judgment against Johnson & Johnson in a lawsuit challenging the drug maker’s marketing of the antipsychotic drug Risperdal. The agreement was the third-largest settlement with a drug maker in U.S. history. The …